Shares of

Celera Genomics

(CRA)

rose sharply this morning after the company said its scientists published an initial interpretation of the human genome sequence that covers 95% of the genetic information contained in humans.

Celera, which is based in Norwalk, Conn., gained $7.10, or 17%, to $48.70 in recent

New York Stock Exchange

trading.

The company now estimates that there are between 26,500 and 30,000 genes in humans. Earlier estimates ranged from 50,000 to more than 140,000. The company also found that humans are 99.9% genetically identical and determined that each person's genetic code differs only slightly from any other individual.

"We firmly believe that our work will stand the test of time and will be the foundation for discovery leading to potential cures and treatments for illness," Celera said.

The findings will be published in the Feb. 16 issue of the journal

Science

.